WallStreetZenWallStreetZen

NASDAQ: CNTB
Connect Biopharma Holdings Ltd Stock

$1.18-0.08 (-6.35%)
Updated Feb 28, 2024
CNTB Price
$1.18
Fair Value Price
$1.38
Market Cap
$64.95M
52 Week Low
$0.54
52 Week High
$2.84
P/E
-0.77x
P/B
0.51x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$83.94M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.12
Operating Cash Flow
-$77M
Beta
0.66
Next Earnings
Apr 15, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CNTB Overview

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company developing immune modulators for the treatment of serious autoimmune diseases and inflammation. Its lead candidates are CBP-201, a treatment for inflammatory allergic diseases (atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps), CBP-307, for the treatment of autoimmune-related inflammation diseases, CBP-174 to treat chronic itch associated with skin inflammation, and CBP-233 to treat T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CNTB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CNTB ($1.18) is undervalued by 14.68% relative to our estimate of its Fair Value price of $1.38 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CNTB ($1.18) is not significantly undervalued (14.68%) relative to our estimate of its Fair Value price of $1.38 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CNTB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CNTB due diligence checks available for Premium users.

Be the first to know about important CNTB news, forecast changes, insider trades & much more!

CNTB News

Valuation

CNTB fair value

Fair Value of CNTB stock based on Discounted Cash Flow (DCF)
Price
$1.18
Fair Value
$1.38
Undervalued by
14.68%
CNTB ($1.18) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CNTB ($1.18) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CNTB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CNTB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.77x
Industry
13.96x
Market
35.52x

CNTB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.51x
Industry
6.14x
CNTB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CNTB's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
CNTB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$143.8M
Liabilities
$15.4M
Debt to equity
0.12
CNTB's short-term assets ($137.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CNTB's short-term assets ($137.52M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CNTB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
CNTB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CNTB vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CNTB$64.95M-6.35%-0.77x0.51x
CDTX$65.11M-1.23%-1.85x8.10x
RZLT$64.19M-4.14%-1.47x0.70x
MLEC$65.74M+6.06%N/A7.39x
ACHL$64.03M+5.37%-0.83x0.42x

Connect Biopharma Holdings Stock FAQ

What is Connect Biopharma Holdings's quote symbol?

(NASDAQ: CNTB) Connect Biopharma Holdings trades on the NASDAQ under the ticker symbol CNTB. Connect Biopharma Holdings stock quotes can also be displayed as NASDAQ: CNTB.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.

What is the 52 week high and low for Connect Biopharma Holdings (NASDAQ: CNTB)?

(NASDAQ: CNTB) Connect Biopharma Holdings's 52-week high was $2.84, and its 52-week low was $0.54. It is currently -58.45% from its 52-week high and 120.56% from its 52-week low.

How much is Connect Biopharma Holdings stock worth today?

(NASDAQ: CNTB) Connect Biopharma Holdings currently has 55,041,247 outstanding shares. With Connect Biopharma Holdings stock trading at $1.18 per share, the total value of Connect Biopharma Holdings stock (market capitalization) is $64.95M.

Connect Biopharma Holdings stock was originally listed at a price of $18.49 in Mar 19, 2021. If you had invested in Connect Biopharma Holdings stock at $18.49, your return over the last 2 years would have been -93.62%, for an annualized return of -74.74% (not including any dividends or dividend reinvestments).

How much is Connect Biopharma Holdings's stock price per share?

(NASDAQ: CNTB) Connect Biopharma Holdings stock price per share is $1.18 today (as of Feb 28, 2024).

What is Connect Biopharma Holdings's Market Cap?

(NASDAQ: CNTB) Connect Biopharma Holdings's market cap is $64.95M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Connect Biopharma Holdings's market cap is calculated by multiplying CNTB's current stock price of $1.18 by CNTB's total outstanding shares of 55,041,247.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.